Involvement of plasminogen activator inhibitor-1 and its related molecules in atrial fibrosis in patients with atrial fibrillation
Open Access
- 2 June 2021
- Vol. 9, e11488
- https://doi.org/10.7717/peerj.11488
Abstract
Atrial fibrillation is the most common form of cardiac arrhythmia. Atrial fibrosis is a significant feature of atrial fibrillation though its mechanism is not well understood. We searched the Gene Expression Omnibus database to compare mRNA expression patterns between atrial fibrillation and sinus rhythm samples; one hundred and forty eight differentially expressed genes were identified. Most of these genes were significantly enriched in the extracellular matrix organization process and collagen-activated tyrosine kinase receptor signaling pathway. To screen hub genes involved in atrial fibrosis, we constructed a protein-protein interaction network and found that three hub genes (SERPINE1/plasminogen activator inhibitor-1/PAI-1, TIMP Metallopeptidase Inhibitor 3/TIMP3 and decorin/DCN) play vital roles in atrial fibrosis, especially plasminogen activator inhibitor-1. Elevated plasminogen activator inhibitor-1 expression was positively correlated with the p53 signaling pathway. Plasminogen activator inhibitor-1 and p53 protein expression levels were verified in patients with sinus rhythm and atrial fibrillation by Western blot analysis. Compared with the sinus rhythm controls, p53 and plasminogen activator inhibitor-1 protein expressions were upregulated in the atrial tissues of patients with atrial fibrillation. p53 was also found to regulate plasminogen activator inhibitor-1 based on the results of cellular and molecular experiments. Thus, the p53/plasminogen activator inhibitor-1 signaling axis may participate in the pathophysiological processes of atrial fibrillation, and plasminogen activator inhibitor-1 may serve as a new therapeutic biomarker in atrial fibrillation.Funding Information
- National Key Research and Development Project (2018YFC1312502)
- National Natural Science Foundation of China (81670314, 81870254)
- Guangzhou Municipal Science and Technology Project (201804010059)
- High-level Hospital Construction Plan (DFJH201808)
This publication has 34 references indexed in Scilit:
- Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease managementTrends in Cardiovascular Medicine, 2022
- Fibronectin Adsorption on Electrospun Synthetic Vascular Grafts Attracts Endothelial Progenitor Cells and Promotes Endothelialization in Dynamic In Vitro CultureCells, 2020
- Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK studyEP Europace, 2020
- Heterogeneity of the action potential duration is required for sustained atrial fibrillationJCI Insight, 2019
- Involvement of Apelin/APJ Axis in Thrombogenesis in Valve Heart Disease Patients with Atrial FibrillationInternational Heart Journal, 2019
- Global Transcriptome Analysis of Brown Adipose Tissue of Diet-Induced Obese MiceInternational Journal of Molecular Sciences, 2018
- Identification of long non-coding RNAs involved in neuronal development and intellectual disabilityScientific Reports, 2016
- MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the TaiwaneseInternational Journal of Molecular Sciences, 2016
- A personalized committee classification approach to improving prediction of breast cancer metastasisBioinformatics, 2014
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networksBioinformatics, 2009